Definitive Contract HT001118C0028
Award Date
9/7/18
Potential Completion Date
12/9/19
Potential Value
$6M
Federal Agency
Defense Health Agency
Awardee
Leidos, Inc.
Ultimate Awardee
Leidos Holdings, Inc.
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92106, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $16,915,382.36 cost-plus-fixed-fee contract awarded by the Bureau of Medicine and Surgery of the Department of Defense (DOD) to Leidos, Inc. for DOD HIV/AIDS Prevention Program consultant services. The contract does not have a set-aside designation. Leidos is performing this research and development contract through its Leidos Services Operating Segment, which does business as SAIC. Major subcontractors include the University of California, San Diego and several individual consultants....
This is a delivery order contract awarded by the Defense Health Agency to Leidos, Inc. for $1,012,969.33 to provide military infectious diseases research program meeting support services. The contract will run through February 26, 2028 and is a cost-plus-fixed-fee type. Leidos, Inc. is the prime contractor, operating through its Leidos Services Operating Segment division and doing business as SAIC. The contract was not set aside for any specific business categories. Leidos, Inc. is a large,...
This is a $6,948,439.91 firm fixed-price definitive contract awarded by the Defense Health Agency to Seneca Telecommunications, LLC, a tribally-owned small business, for project management support services for the Department of Defense HIV/AIDS Prevention Program (DHAPP). The contract has an ultimate completion date of August 22, 2024. This award was not set aside. The contract was originally awarded on August 23, 2023, and a bridge contract modification has been issued to extend the period of...
This contract was awarded by the Defense Health Agency (DHA) to Leidos, Inc. (Leidos) for delivery order services. The contract has a potential value of $5,617,571.35 and is a cost-plus-fixed-fee type. The contract does not have a set-aside designation. Leidos, through its Leidos Services Operating Segment doing business as Science Applications International Corporation (SAIC), provides a range of IT, engineering, and scientific solutions to federal agencies, including the DHA. This contract...
This is a cost-plus-fixed-fee delivery order contract awarded by the Defense Health Agency to Leidos, Inc. for Parkinson's research program support services in fiscal year 2024. The contract has a ceiling value of $220,062.07 and a period of performance through April 30, 2025. The contract does not have a set-aside designation. Leidos, a global leader in information technology, engineering, and science solutions, will provide a range of program support services for the Defense Health Agency's...
This is a $1,194,974.16 cost-plus-fixed-fee delivery order awarded to Leidos, Inc. by the Defense Health Agency (DHA) for the Peer Reviewed Medical Research Program. The contract has no set-aside designation and runs through March 18, 2026. Leidos, operating through its Leidos Services Operating Segment and doing business as SAIC, is a global leader in information technology, engineering, and science solutions. The company has secured numerous prime and subcontract awards across federal...
This federal contract award, with an ID of 75N91019D00024|75N91019F00137, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The $9,235,930.00 cost-plus-fixed-fee contract was awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., to complete HIV studies intended to describe the characteristics, course, and treatment response of HIV disease in the study population. The...
This is a federal contract award from the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The $5,074,782.64 contract is for HIV MPER BNABS (monoclonal antibodies) for prevention, therapy, or cure. It is a delivery order contract with a cost-no-fee pricing type. The contract has an ultimate completion date of May 24, 2023 and was awarded on September 26, 2015. There is no set-aside designation mentioned for this contract. Leidos Biomedical...
This federal contract award was made by the Defense Health Agency (DHA) to Leidos, Inc., a global technology and engineering solutions provider. The award, valued at $481,757.01, is for fiscal year 2024 support services for the Prostate Cancer Research Program. The contract is a cost-plus-fixed-fee type delivery order with a completion date of June 30, 2025. The award was not set aside for any specific business categories. Leidos, through its Leidos Services Operating Segment division and...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $26,662,207.00 Cost Plus Fixed Fee delivery order contract to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., to support the development of Anti-HIV Broadly Neutralizing Monoclonal Antibodies for AMP Trials. The contract has a completion date of September 29, 2023 and was awarded on September 30, 2018. The work...